Isn’t it about time we moved forward on cannabis legalization? 🌱
A new Gallup poll confirms what we’ve known for years: the majority of Americans—across both parties—support cannabis legalization. This isn’t fringe anymore; it’s a mainstream position backed by science and WE THE PEOPLE! The benefits of cannabis as a therapeutic option have been thoroughly researched, with data supporting its role in pain management, mental health, […]
The Endocannabinoid System: Bridging Healthcare’s Knowledge Gap
Recent research has revealed the endocannabinoid system’s fundamental role in human health, regulating critical functions from learning and memory to pain control and emotional processing. The ECS plays a particularly vital role in nervous system development and neuronal activity. Three Key Actions Needed: Increase research funding to expand our understanding of the ECS Integrate comprehensive […]
THC is not alcohol, and must be evaluated seperately!
When evaluating cannabis usage, it’s crucial to rely on scientific knowledge rather than outdated social comparisons, particularly with alcohol. A recent study revealed no direct link between THC levels in the blood and driving impairment, challenging many current impaired driving laws. Unlike alcohol, (which people still have a hard time understanding) THC affects each person […]
It is (and continues to be) time to normalize cannabis!
I haven’t posted about cannabis reform in a while—honestly, it’s exhausting seeing the same conversations play out without progress. But the recent move by the American Institute of Certified Public Accountants (AICPA), representing 400,000 professionals, caught my attention. The AICPA is urging the IRS to update its 280E tax code, which unfairly penalizes cannabis businesses […]
Medical Cannabis Reform is Gaining Serious Momentum!
Both my parents were hugely active in the AMA. This recent AMA-backed study shows 71% of chronic pain patients and 59% of doctors support national legalization of medical marijuana. Even more powerful—64% of patients and 51% of physicians want insurance companies to cover the cost of cannabis treatments, is a huge step toward making cannabis […]
A Long Journey Ahead!
It’s inspiring to witness the progress we’ve made in the cannabis reform conversation. After years of advocacy, it’s now being recognized on a national platform, and this moment feels like an acknowledgment of the hard work so many have put into changing perceptions. I sense a modicum of respect finally being afforded to those who […]
DEA’s Bold Move
The DEA’s bold move to simplify the cannabis medical use test, in my opinion, is a game changer, making rescheduling to Schedule III a central policy issue. As scientific evidence and public demand grow, can any political candidate afford to sidestep cannabis reform? Rescheduling opens the door for broader access, research, health breakthroughs, and economic […]
DEA Simplifies Cannabis Medical Use Test
The DEA has recently endorsed a new, simplified two-step test for determining the accepted medical use of cannabis. This shift from the previous five-part criteria could significantly impact the potential rescheduling of marijuana from Schedule I to Schedule III. Key developments: New test focuses on two questions about medical treatment use Department of Justice proposed […]
Nurses and Cannabis Advocacy!
Reflecting on my father’s dedication as a surgeon, I remember how he always emphasized the indispensable role of nurses in patient care and advocacy. Nurses are extremely important healthcare providers, unsung heroes, and compassionate advocates who ensure patients’ voices are heard, especially in critical moments.
The Strategic Delay in Marijuana Rescheduling: Implications and Consequences
The anticipated rescheduling of marijuana from Schedule I to Schedule III has been delayed until after the 2024 U.S. presidential election. This decision has far-reaching implications for the cannabis industry, medical research, and public health policy. Potential Impact of Schedule III Status Tax Relief: Rescheduling would alleviate the harsh taxation under IRC 280E, potentially saving […]